164 related articles for article (PubMed ID: 12525835)
1. Viral-mediated delivery of the late-infantile neuronal ceroid lipofuscinosis gene, TPP-I to the mouse central nervous system.
Haskell RE; Hughes SM; Chiorini JA; Alisky JM; Davidson BL
Gene Ther; 2003 Jan; 10(1):34-42. PubMed ID: 12525835
[TBL] [Abstract][Full Text] [Related]
2. AAV2-mediated CLN2 gene transfer to rodent and non-human primate brain results in long-term TPP-I expression compatible with therapy for LINCL.
Sondhi D; Peterson DA; Giannaris EL; Sanders CT; Mendez BS; De B; Rostkowski AB; Blanchard B; Bjugstad K; Sladek JR; Redmond DE; Leopold PL; Kaminsky SM; Hackett NR; Crystal RG
Gene Ther; 2005 Nov; 12(22):1618-32. PubMed ID: 16052206
[TBL] [Abstract][Full Text] [Related]
3. Long-term gene transfer to mouse fetuses with recombinant adenovirus and adeno-associated virus (AAV) vectors.
Mitchell M; Jerebtsova M; Batshaw ML; Newman K; Ye X
Gene Ther; 2000 Dec; 7(23):1986-92. PubMed ID: 11175309
[TBL] [Abstract][Full Text] [Related]
4. Lysosomal degradation of cholecystokinin-(29-33)-amide in mouse brain is dependent on tripeptidyl peptidase-I: implications for the degradation and storage of peptides in classical late-infantile neuronal ceroid lipofuscinosis.
Bernardini F; Warburton MJ
Biochem J; 2002 Sep; 366(Pt 2):521-9. PubMed ID: 12038963
[TBL] [Abstract][Full Text] [Related]
5. Adeno-associated virus 2-mediated gene therapy decreases autofluorescent storage material and increases brain mass in a murine model of infantile neuronal ceroid lipofuscinosis.
Griffey M; Bible E; Vogler C; Levy B; Gupta P; Cooper J; Sands MS
Neurobiol Dis; 2004 Jul; 16(2):360-9. PubMed ID: 15193292
[TBL] [Abstract][Full Text] [Related]
6. Widespread gene transduction to the central nervous system by adenovirus in utero: implication for prenatal gene therapy to brain involvement of lysosomal storage disease.
Shen JS; Meng XL; Maeda H; Ohashi T; Eto Y
J Gene Med; 2004 Nov; 6(11):1206-15. PubMed ID: 15459963
[TBL] [Abstract][Full Text] [Related]
7. AAV2-mediated ocular gene therapy for infantile neuronal ceroid lipofuscinosis.
Griffey M; Macauley SL; Ogilvie JM; Sands MS
Mol Ther; 2005 Sep; 12(3):413-21. PubMed ID: 15979943
[TBL] [Abstract][Full Text] [Related]
8. Simian immunodeficiency virus vector pseudotypes differ in transduction efficiency and target cell specificity in brain.
Liehl B; Hlavaty J; Moldzio R; Tonar Z; Unger H; Salmons B; Günzburg WH; Renner M
Gene Ther; 2007 Sep; 14(18):1330-43. PubMed ID: 17611586
[TBL] [Abstract][Full Text] [Related]
9. Safety of direct administration of AAV2(CU)hCLN2, a candidate treatment for the central nervous system manifestations of late infantile neuronal ceroid lipofuscinosis, to the brain of rats and nonhuman primates.
Hackett NR; Redmond DE; Sondhi D; Giannaris EL; Vassallo E; Stratton J; Qiu J; Kaminsky SM; Lesser ML; Fisch GS; Rouselle SD; Crystal RG
Hum Gene Ther; 2005 Dec; 16(12):1484-503. PubMed ID: 16390279
[TBL] [Abstract][Full Text] [Related]
10. Feline immunodeficiency virus vectors. Gene transfer to mouse retina following intravitreal injection.
Derksen TA; Sauter SL; Davidson BL
J Gene Med; 2002; 4(5):463-9. PubMed ID: 12221638
[TBL] [Abstract][Full Text] [Related]
11. Retargeting of adenoviral vectors to neurons using the Hc fragment of tetanus toxin.
Schneider H; Groves M; Mühle C; Reynolds PN; Knight A; Themis M; Carvajal J; Scaravilli F; Curiel DT; Fairweather NF; Coutelle C
Gene Ther; 2000 Sep; 7(18):1584-92. PubMed ID: 11021597
[TBL] [Abstract][Full Text] [Related]
12. Clinical protocol. Administration of a replication-deficient adeno-associated virus gene transfer vector expressing the human CLN2 cDNA to the brain of children with late infantile neuronal ceroid lipofuscinosis.
Crystal RG; Sondhi D; Hackett NR; Kaminsky SM; Worgall S; Stieg P; Souweidane M; Hosain S; Heier L; Ballon D; Dinner M; Wisniewski K; Kaplitt M; Greenwald BM; Howell JD; Strybing K; Dyke J; Voss H
Hum Gene Ther; 2004 Nov; 15(11):1131-54. PubMed ID: 15610613
[TBL] [Abstract][Full Text] [Related]
13. Antioxidant enzyme gene delivery to protect from HIV-1 gp120-induced neuronal apoptosis.
Agrawal L; Louboutin JP; Reyes BA; Van Bockstaele EJ; Strayer DS
Gene Ther; 2006 Dec; 13(23):1645-56. PubMed ID: 16871233
[TBL] [Abstract][Full Text] [Related]
14. Systemic hyperosmolality improves beta-glucuronidase distribution and pathology in murine MPS VII brain following intraventricular gene transfer.
Ghodsi A; Stein C; Derksen T; Martins I; Anderson RD; Davidson BL
Exp Neurol; 1999 Nov; 160(1):109-16. PubMed ID: 10630195
[TBL] [Abstract][Full Text] [Related]
15. Adenovirus-mediated prenatal gene transfer to murine central nervous system.
Shen JS; Meng XL; Ohashi T; Eto Y
Gene Ther; 2002 Jun; 9(12):819-23. PubMed ID: 12040464
[TBL] [Abstract][Full Text] [Related]
16. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.
Okada T; Caplen NJ; Ramsey WJ; Onodera M; Shimazaki K; Nomoto T; Ajalli R; Wildner O; Morris J; Kume A; Hamada H; Blaese RM; Ozawa K
J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990
[TBL] [Abstract][Full Text] [Related]
17. Long-term retinal transgene expression with FIV versus adenoviral vectors.
Loewen N; Leske DA; Cameron JD; Chen Y; Whitwam T; Simari RD; Teo WL; Fautsch MP; Poeschla EM; Holmes JM
Mol Vis; 2004 Apr; 10():272-80. PubMed ID: 15094709
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of prenatal intra-amniotic LAMB3 gene delivery in a mouse model of Herlitz disease.
Mühle C; Neuner A; Park J; Pacho F; Jiang Q; Waddington SN; Schneider H
Gene Ther; 2006 Dec; 13(23):1665-76. PubMed ID: 16871230
[TBL] [Abstract][Full Text] [Related]
19. Integration of active human beta-galactosidase gene (100 kb) into genome using HSV/AAV amplicon vector.
Oehmig A; Cortés ML; Perry KF; Sena-Esteves M; Fraefel C; Breakefield XO
Gene Ther; 2007 Jul; 14(14):1078-91. PubMed ID: 17460718
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotective effect of adenoviral-mediated gene transfer of TIMP-1 and -2 in ischemic brain injury.
Magnoni S; Baker A; Thomson S; Jordan G; George SJ; McColl BW; McCulloch J; Horsburgh K
Gene Ther; 2007 Apr; 14(7):621-5. PubMed ID: 17235293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]